InnovAge Holding Appoints Jennifer Browne President, COO, Effective June 8
Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. INNV | 0.00 |
InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced that Jennifer Browne has been appointed President and Chief Operating Officer, effective June 8, 2026.
